Please Wait
Applying Filters...
menu
    • menu
    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Navacaprant

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Neumora Hosts Roundtable On Navacaprant's Potential In Neuropsychiatric Disorder
    Neumora Hosts Roundtable On Navacaprant's Potential In Neuropsychiatric Disorder

    14 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/14/2929913/0/en/Neumora-Therapeutics-to-Host-Key-Opinion-Leader-Roundtable-to-Discuss-the-Potential-of-Navacaprant-in-Neuropsychiatric-Disorders.html

    GLOBENEWSWIRE
    14 Aug 2024
    Share Share
    Neumora Initiates Navacaprant Phase 2 Study In Bipolar Depression
    Neumora Initiates Navacaprant Phase 2 Study In Bipolar Depression

    14 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/14/2881193/0/en/Neumora-Therapeutics-Announces-Initiation-of-Phase-2-Study-of-Navacaprant-in-Bipolar-Depression.html

    GLOBENEWSWIRE
    14 May 2024
    Share Share
    Neumora’s schizophrenia drug hit with clinical hold
    Neumora’s schizophrenia drug hit with clinical hold

    16 Apr 2024

    // BIOPHARMADIVE

    https://www.biopharmadive.com/news/neumora-clinical-hold-schizophrenia-drug-fda/713182/

    BIOPHARMADIVE
    16 Apr 2024
    Share Share